期刊文献+

hTR反义寡核苷酸对急性白血病原代细胞端粒酶活性及凋亡的影响 被引量:2

The effect of human telomerase RNA(hTR) antisense oligodeoxynucleotides on telomerase acitvity and apoptosis in primary acute leukemia cells
下载PDF
导出
摘要 目的 探讨端粒酶RNA(hTR)反义寡核苷酸 (ASODN)对急性白血病 (AL)原代细胞端粒酶活性及细胞凋亡的影响。方法 应用与人hTR起始密码子互补的硫代ASODN处理AL原代细胞 ,用台盼蓝拒染的方法计数活细胞 ,用端粒酶重复扩增分析 (TRAP) -PCR -ELISA检测法观察端粒酶活性的变化 ,用Giemsa染色、Hoechst332 5 8+PI双染荧光显微镜检查及流式细胞仪检测凋亡细胞的发生。结果 经hTR -ASODN作用后 ,AL原代细胞端粒酶活性明显受到抑制 ,并与ASODN的浓度和处理时间相关 ,10 μmol/LASODN在作用 72h时端粒酶活性为( 0 0 95± 0 0 6 ) ,较细胞对照组 ( 1 15 4± 0 15 )下调明显 (P <0 0 1) ;在作用第 5天经荧光显微镜可观察到ASODN组细胞凋亡形态学变化。流式细胞仪检测到其凋亡率为 ( 31 72± 8 6 4 ) ,与细胞对照组的凋亡率 ( 6 33± 0 91)比较 ,差异有显著性 (P <0 0 1)。结论 hTR -ASODN可明显抑制AL原代细胞端粒酶活性并诱导其凋亡 。 Objective To evalutae the effect of hTR ASODN on telomerase activity and apoptosis in primary acute leukemia(AL) cells. Methods Primary AL cells were treated with phosphorothioate ASODN complementary to the template region of hTR in vivo. The change in telomerase activity was detemined by polymerase chain reaction enzyme-linked immunoassay(PCR-ELISA). Apotosis was analyzed by Hoechst 33258+PI and flow cytometry. Results Telomerase activity was significantly suppresssed by ASODN and the effect was correlated with concentrations of ASODN and treating time. Apoptosis rates of primary AL cells treated with ASODN for 5 day significantly increased. But similar effect was not observed in SODN group. Conclusion ASODN complementary to the region of hTR can significantly suppress the telomerase activity and induce cell apoptosis. Telomerase may play an important role in the carcinogensis of leukemia and can be a new target of treatment for leukemia.
出处 《广东医学》 CAS CSCD 2004年第12期1379-1381,共3页 Guangdong Medical Journal
基金 广东省自然科学基金资助项目 (编号 :0 43 0 0 90 2 ) 广州市重点科技项目 (编号 :2 0 0 1-Z -0 3 7-0 1)
关键词 端粒酶活性 原代细胞 ASODN AL 反义寡核苷酸 急性白血病 凋亡 起始密码子 活细胞 荧光显微镜 Telomerase RNA Antisense Oligodeoxynucleotide Acute Leukemia Apoptosis
  • 相关文献

参考文献7

  • 1Ohyashiki K, Lwama H, Tauchi T, et al. Telomere dynamics and genetic instablity in disease progression of chronic myeloid leukemia. Leuk Lymphoma, 2000,40(1 - 2) :49 被引量:1
  • 2Devemy E, Li B, Tao M, et al. Poor prognosis acute myelogenous leukemia:3 - biological and molecular biological changes during remission induction therapy. Leuk Res, 2001,25(9) :783 被引量:1
  • 3Li B, Yang J, TaoM, etal. Poor prognosis acutemyelogenous leukemia2 -biological and molecular biological characteristics and treatment outcome. Leuk Res, 2000,24(9):777 被引量:1
  • 4Kushner D, Paranjape J, Bandyopadhyay B, et al. 2 - 5 antsense directed against telomerase RNAproduces apoptosis in ovarian cancer cells. Gynecol Oncol,2000,76(2): 183 被引量:1
  • 5Villa R, Folini M, Lualdi S, et al. Inhibition of telomerase activity by a cell - penetrating petide nucleic acid construct in human melanoma cells.FEBS- Lett, 2000,473(2):2241 被引量:1
  • 6Zhu X, Kumar R, Mandal M, et al. Cell cycle- dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA, 1996,93:6091 被引量:1
  • 7Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science, 1995,269(5228): 1236 被引量:1

同被引文献45

  • 1肖扬,张宏斌,张洹.急性白血病组织中端粒酶活性与p170共同表达及其临床意义[J].肿瘤防治杂志,2005,12(7):522-524. 被引量:1
  • 2贺庆,朱恩圆,王峥涛,侴桂新,徐珞珊,胡之璧.党参化学成分的研究[J].中国药学杂志,2006,41(1):10-12. 被引量:78
  • 3Lin q'T, Letsolo BT, Jones RE, et al. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis[J]. Blood, 2010 Sep 16, 116(11) : 1899-907. 被引量:1
  • 4White DL.Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance[J]. Leuk-Lymphoma, 2008, 49(6): 1022-3. 被引量:1
  • 5Ghaffari S H, Shayan Asl-N, Jamialahmadi et al. Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival[J]. Ann-Oncol, 2008, 19(11): 1927-34. 被引量:1
  • 6Wang, Y, Fang M, Sun X, et al. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival. Int-J-Lab-Hematol [J]. 2010, 32 (2) : 230-8. 被引量:1
  • 7Novotny L, Rauko P, Schott H. Cytotoxicity and antileukaemic activity of new duplexes linking 3-C-ethynylcytidine and 5-fluorodeoxyuridine.Anticancer-Res[J]. 2010 Dec; 30(12) : 4891-8. 被引量:1
  • 8Abramkin SA; Jungwirth U, Valiahdi SM et al. {(1R, 2R, 4R)-4- methyl-l, 2-eycloh exanediamine} oxalatoplatinum (II): a novel enantiomerieally pure oxaliplatin derivative showing improved anti-cancer activity in vivo [J]. J-Med-Chem. 2010 Oct 28; 53 (20): 7356-64. 被引量:1
  • 9Acob D, Davis JJ, Zhang L, et al. Suppression of pancreatic tumor growth in the liver by systemic administration of theTRAILgene driven by the hTERT promoter [J]. Cancer GeneTher. 2005, 12(2): 109-115. 被引量:1
  • 10Calado RT. Telomeres and marrow failure. Hematology Am Soc Hematol Educ Program, 2009:338-343. 被引量:1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部